相关实验视频

Updated: Jun 16, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

膀性口炎病毒 (VSV) 的工程用于调节细胞死亡和抗瘤免疫力

Tao Yang¹, Yi Yuan¹, Feng Ma²

¹National Key Laboratory of Immunity and Inflammation, and CAMS Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China.

Methods in molecular biology (Clifton, N.J.)

|June 14, 2025

概括

膀性口腔炎病毒 (VSV) 显示出癌症治疗的前景. 工程VSV与proapoptotic基因XAF1增强其在打击瘤和增强抗瘤免疫力的有效性.

科学领域:

病毒学病毒学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

膀性口腔炎病毒 (VSV) 是一种负意义的RNA病毒,是型病毒疗法和疫苗开发的有希望的平台.
它的广泛宿主范围,快速复制和易于修改的基因组使其适合治疗传染病和瘤.
反向遗传学和合成生物学方面的进步使VSV的精确工程能够用于增强的治疗应用.

研究的目的:

为癌症治疗提供VSV工程技术的全面概述.
专注于将 XAF1 亲细胞遗传基因纳入 VSV.
详细介绍设计VSV与XAF1的实验程序,以提高抗瘤功效.

主要方法:

使用分子生物学技术对膀性口腔炎病毒 (VSV) 基因组进行工程.
在VSV基因组中纳入前性基因XAF1.
对VSV基因组修改和应用的详细实验程序.

主要成果:

具有细胞死亡元素的工程VSV显示出相当大的抗瘤疗效.
预遗传基因XAF1可以有效地纳入VSV.
VSV工程策略旨在增强抗瘤免疫力.

结论:

改造的VSV,特别是带有XAF1的亲细胞遗传基因,为型病毒治疗提供了一个强有力的策略.
对VSV工程的进一步研究可以扩大其在癌症治疗中的治疗应用.
这些方法有可能提高VSV在抗瘤免疫和其他治疗领域的疗效.

关键词:

反瘤免疫力抗瘤免疫力细胞死亡细胞死亡反向遗传系统是一种逆向遗传系统.这是VSVV的VSV.

更多相关视频

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.